LEADER 00822nam0-22003131i-450-
001 990008042830403321
005 20050408113521.0
010   $a0-12-312085-3
035   $a000804283
035   $aFED01000804283
035   $a(Aleph)000804283FED01
035   $a000804283
100   $a20050408d2003----km-y0itay50------ba
101 0 $aeng
102   $aNL
105   $aa-------001yy
200 1 $aCarbohydrates$fHelen M.I.Osborn
210   $aAmsterdam$cAcademic Press$d2003
215   $aXXII, 430 p.$cill.$d24 cm
225 1 $aBest synthetic methods
610 0 $aCarboidrati
700  1$aOsborn,$bHelen M.I.$0497295
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990008042830403321
952   $aDCOB6-504$b4309$fDCOB
959   $aDCOB
996   $aCarbohydrates$9752677
997   $aUNINA

LEADER 01259nam2-2200385---450-
001 990006052300203316
005 20150623155712.0
010   $a978-3-319-09664-3
010   $a978-3-319-09665-0 (e-book)
035   $a000605230
035   $aUSA01000605230
035   $a(ALEPH)000605230USA01
035   $a000605230
100   $a20110331d2014----km-y0itay50------ba
101   $aeng
102   $aDE
105   $aa---||||001yy
200 1 $aHigh density lipoproteins$efrom biological understandind to clinical exploitation$fArnold von Echardstein, Dimitris Kardassis editors
210   $aCham [etc.]$cSpringer$dcopyr. 2014
215   $aXIII, 694 p.$cill.$d24 cm
225 2 $aHandbook of experimental pharmacology$v224
410  0$1001000320432$12001$aHandbook of experimental pharmacology$v, 224
606 0 $aLipoproteine$2BNCF
676   $a572.68
702  1$aECKARDSTEIN,$bArnold: von
702  1$aKARDASSIS,$bDimitris
801  0$aIT$bsalbc$gISBD
912   $a990006052300203316
951   $a572.68 HIG 1$b5863 Farm.$c572$d00330931
959   $aBK
969   $aFAR
979   $aPAOLA$b90$c20150623$lUSA01$h1237
979   $aPAOLA$b90$c20150623$lUSA01$h1557
996   $aHigh density lipoproteins$91102727
997   $aUNISA